Risk-reducing mastectomy (RRM) nearly eliminates the BC risk in female BRCA1/2 PV carriers and should be discussed with all patients, with thoughtful consideration of the personal nature of this decision for affected individuals [17]. This evidence concerns the gene BRCA1 and breast cancer.